Efficacy and safety of FangJiHuangQi granule in patients with heart failure: a protocol of randomized, placebo-controlled trial - Top-Institutions - MDSpire

Efficacy and safety of FangJiHuangQi granule in patients with heart failure: a protocol of randomized, placebo-controlled trial

  • By

  • Deng Pan

  • Lu Liang

  • Qian Zhao

  • Jianwu Zheng

  • Houyong Zhu

  • Yu Wang

  • Cheng Bao

  • Tielong Chen

  • May 29, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Tianjin University of Traditional Chinese Medicine
    Tianjin University of Traditional Chinese Medicine

    Tianjin, Tianjin

    Key Differentiators

    • Cardiology

  • #2

    Hangzhou Hospital of Traditional Chinese Medicine
    Hangzhou Hospital of Traditional Chinese Medicine

    Hangzhou, Zhejiang

    Key Differentiators

    • Cardiology

  • #3

    German Society for Prevention and Rehabilitation
    German Society for Prevention and Rehabilitation

    N/A, N/A

    Key Differentiators

    • Cardiology

Original Source(s)

Efficacy and safety of FangJiHuangQi granule in patients with heart failure: a protocol of randomized, placebo-controlled trial

  • by Deng Pan, Lu Liang, Qian Zhao, Jianwu Zheng, Houyong Zhu, Yu Wang, Cheng Bao, Tielong Chen

  • May 29, 2026

Related Content

Correction: Association between systemic immune-inflammation index(SII) and all-cause and cardiovascular mortality in heart failure patients: a single-center retrospective analysis

Cardiac magnetic resonance biomarkers for cardiovascular complications in diabetes: a systematic review and meta-analysis

Case Report: Selective metal cell excision during open TAVR implantation preserves coronary access while maintaining valve integrity and function